ScholarLens Back to search
2007•Critical CareOpen access

Introduction: severe sepsis and drotrecogin alfa (activated)

Antonio Artigas, Claude Martin

Open full text 1 citations

Abstract

The supplement concludes with three practical clinical articles.In the first of these, Laterre [11] reviews all large clinical trials of rhAPC.

Open-access reader

About this research paper

What this paper is about

The supplement concludes with three practical clinical articles.In the first of these, Laterre [11] reviews all large clinical trials of rhAPC.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

The supplement concludes with three practical clinical articles.In the first of these, Laterre [11] reviews all large clinical trials of rhAPC.

Key concepts: Drotrecogin alfa, Medicine, Severe sepsis, Intensive care medicine, Sepsis, Septic shock, Internal medicine

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Introduction: severe sepsis and drotrecogin alfa (activated) — Research Paper | ScholarLens